Metraipolis › archive › dc_5d64cb495cd8

Cost-effectiveness of stem cell therapy versus standard of care for acute and subacute ischemic stroke — Europe PMC PMID:42166449

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42166449
DOI: 10.1371/journal.pone.0349756
License (as archived): solo-consultazione
Archived: 2026-10-08T01:21:51.114Z
SHA-256 of the archived text: 716dac08227c9133d9d357c799b53605423a112b3cf6662986fb8475ccaa6f57
Stable URL of this page: https://metraipolis.com/documento/dc_5d64cb495cd8

How to cite

Cost-effectiveness of stem cell therapy versus standard of care for acute and subacute ischemic stroke — Europe PMC PMID:42166449 — Europe PMC (en), https://europepmc.org/article/MED/42166449 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5d64cb495cd8 (Metraipolis archive dc_5d64cb495cd8, sha256 716dac08227c9133d9d357c799b53605423a112b3cf6662986fb8475ccaa6f57)

BibTeX

@misc{dc5d64cb495cd8,
  title = {Cost-effectiveness of stem cell therapy versus standard of care for acute and subacute ischemic stroke — Europe PMC PMID:42166449},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42166449},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5d64cb495cd8; sha256 716dac08227c9133d9d357c799b53605423a112b3cf6662986fb8475ccaa6f57},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42166449. Agents can read the archived copy with the MCP tool read_document.